The antimicrobial resistance pattern of cultured human methanogens reflects the unique phylogenetic position of archaea

Journal of Antimicrobial Chemotherapy

Volumn 66, Issue 9, 2011, Pages 2038-2044

  Dridi, Bédis ^a   Fardeau, Marie Laure ^b   Ollivier, Bernard ^b   Raoult, Didier ^a   Drancourt, Michel ^a  

^a AIX MARSEILLE UNIVERSITÉ   (France)

^b INSTITUT DE RECHERCHE POUR LE DÉVELOPPEMENT   (France)

Author keywords

Antimicrobial Agents; Bacitracin; Chloramphenicol; Methanobrevibacter Oralis; Methanobrevibacter Smithii; Methanogenic Archaea; Methanomassiliicoccus Luminyensis; Methanosphaera Stadtmanae; Metronidazole; Microbiota; Squalamine; Susceptibility Testing

Indexed keywords

AMPHOTERICIN B; AMPICILLIN; BACITRACIN; CHLORAMPHENICOL; GENTAMICIN; METRONIDAZOLE; OFLOXACIN; ORNIDAZOLE; RIFAMPICIN; SQUALAMINE; STREPTOMYCIN; TETRACYCLINE; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM CULTURE; BACTERIUM ISOLATE; METHANOBREVIBACTER ORALIS; METHANOBREVIBACTER SMITHII; METHANOGENIC ARCHAEON; METHANOMASSILIICOCCUS LUMINYENSIS; METHANOSPHAERA STADTMANAE; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; NUCLEOTIDE SEQUENCE; PHYLOGENY;

ANTI-BACTERIAL AGENTS; ARCHAEA; BACTERIA; BACTERIAL INFECTIONS; CHLORAMPHENICOL O-ACETYLTRANSFERASE; COMPUTATIONAL BIOLOGY; DRUG RESISTANCE, BACTERIAL; HUMANS; METHANE; METHANOBACTERIACEAE; MICROBIAL SENSITIVITY TESTS; PHYLOGENY;

EID: 80051703060     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkr251     Document Type: Article

References (33)

1. Woese CR, Fox GE. Phylogenetic structure of the prokaryotic domain: the primary kingdoms. Proc Natl Acad Sci USA 1977; 74: 5088-90.
2. Boyer M, Madoui MA, Gimenez G et al. Phylogenetic and phyletic studies of informational genes in genomes highlight existence of a 4 domain of life including giant viruses. PLoS One 2010; 5: e15530.
3. De Rosa M, Gambacorta A, Gliozzi A. Structure, biosynthesis, and physicochemical properties of archaebacterial lipids. Microbiol Rev 1986; 50: 70-80.
4. Koga Y, Morii H. Biosynthesis of ether-type polar lipids in archaea and evolutionary considerations. Microbiol Mol Biol Rev 2007; 71: 97-120.
5. Ferrari A, Brusa T, Rutili A et al. Isolation and characterization of Methanobrevibacter oralis sp. nov. Curr Microbiol 1994; 29: 7-12.
6. Pecher T, Böck A. In vivo susceptibility of halophilic and methanogenic organisms to protein synthesis inhibitors. FEMS Microbiol Lett 1981; 10: 295-7.
7. Cammarano P, Teichner A, Londei P et al. Insensitivity of archaebacterial ribosomes to protein synthesis inhibitors. Evolutionary implications. EMBO J 1985; 4: 811-6.
8. Londei P, Sanz JL, Altamura S et al. Unique antibiotic sensitivity of archaebacterial polypeptide elongation factors. J Bacteriol 1986; 167: 265-71.
9. Sioud M, Possot O, Elie C et al. Coumarin and quinolone action in archaebacteria: evidence for the presence of a DNA gyrase-like enzyme. J Bacteriol 1988; 170: 946-53.
10. Sanz JL, Rodríguez N, Amils R. The action of antibiotics on the anaerobic digestion process. Appl Microbiol Biotechnol 1996; 46: 587-92.
11. Dermoumi HL, Ansorg RA. Isolation and antimicrobial susceptibility testing of fecal strains of the archaeon Methanobrevibacter smithii. Chemotherapy 2001; 47: 177-83.
12. Dridi B, Henry M, El Kechine A et al. High prevalence of Methanobrevibacter smithii and Methanosphaera stadtmanae detected in the human gut using an improved DNA detection protocol. PLoS One 2009; 4: e7063.
13. Alhanout K, Rolain JM, Brunel JM. Squalamine as an example of a new potent antimicrobial agents class: a critical review. Curr Med Chem 2010; 17: 3909-17.
14. Alhanout K, Malesinki S, Vidal N et al. New insights into the antibacterial mechanism of action of squalamine. J Antimicrob Chemother 2010; 65: 1688-93.
15. Alhanout K, Brunel JM, Ranque S et al. In vitro antifungal activity of aminosterols against moulds isolated from cystic fibrosis patients. J Antimicrob Chemother 2010; 65: 1307-9.
16. Baginski M, Czub J. Amphotericin B and its new derivatives - mode of action. Curr Drug Metab 2009; 10: 459-69.
17. Samuel BS, Hansen EE, Manchester JK et al. Genomic and metabolic adaptations of Methanobrevibacter smithii to the human gut. Proc Natl Acad Sci USA 2007; 104: 10643-8.
18. Fricke WF, Seedorf H, Henne A et al. The genome sequence of Methanosphaera stadtmanae reveals why this human intestinal archaeon is restricted to methanol and H2 for methane formation and ATP synthesis. J Bacteriol 2006; 188: 642-58.
19. Hammes WP, Winter J, Kandler O. The sensitivity of the pseudomurein-containing genus Methanobacterium to inhibitors of murein synthesis. Arch Microbiol 1979; 123: 275-9.
20. Miller TL, Wolin MJ, Conway de Macario E et al. Isolation of Methanobrevibacter smithii from human feces. Appl Environ Microbiol 1982; 43: 227-32.
21. Hilpert R, Winter J, Hammes W et al. The sensitivity of Archaebacteria to antibiotics. Zbl Bakt Hyg 1981; C2: 11-20.
22. Mondy KE, Shannon W, Mundy LM. Evaluation of zinc bacitracin capsules versus placebo for enteric eradication of vancomycin-resistant Enterococcus faecium. Clin Infect Dis 2001; 33: 473-6.
23. Weinstein MR, Dedier H, Brunton J et al. Lack of efficacy of oral bacitracin plus doxycycline for the eradication of stool colonization with vancomycin-resistant Enterococcus faecium. Clin Infect Dis 1999; 29: 361-6.
24. Dudley MN, McLaughlin JC, Carrington G et al. Oral bacitracin vs vancomycin therapy for Clostridium difficile-induced diarrhea. A randomized double-blind trial. Arch Intern Med 1986; 146: 1101-4.
25. Hecht DW. Antimicrobial susceptibility testing of anaerobic bacteria. In: Lorian V, ed. Antibiotics in Laboratory Medicine, 5th edn. Philadelphia: Lippincott Williams & Wilkins, 2005; 144-54.
26. Kelman LM, Kelman Z. Multiple origins of replication in archaea. Trends Microbiol 2004; 12: 399-401.
27. Tocher JH, Edwards DI. Evidence for the direct interaction of reduced metronidazole derivatives with DNA bases. Biochem Pharmacol 1994; 48: 1089-94.
28. Ansorg R, Rath PM, Runde V et al. Influence of intestinal decontamination using metronidazole on the detection of methanogenic archaea in bone marrow transplant recipients. Bone Marrow Transplant 2003; 31: 117-9.
29. Rokosz A, Sawicka-Grzelak A, Kot K et al. Use of the Etest method for antimicrobial susceptibility testing of obligate anaerobes. Med Dosw Mikrobiol 2001; 53: 167-75.
30. Hausen MA, Menna-Barreto RF, Lira DC et al. Synergic effect of metronidazole and pyrantel pamoate on Giardia lamblia. Parasitol Int 2011; 60: 54-8.
31. Heredia-Rojas JA, Torres-Flores AC, Rodriguez-De la Fuente AO et al. Entamoeba histolytica and Trichomonas vaginalis: trophozoite growth inhibition by metronidazole electro-transferred water. Exp Parasitol 2011; 127: 80-3.
32. Oxley AP, Lanfranconi MP, Wü rdemann D et al. Halophilic archaea in the human intestinal mucosa. Environ Microbiol 2010; 12: 2398-410.
33. Jones JB, Bowers B, Stadtman TC. Methanococcus vannielii: ultrastructure and sensitivity to detergents and antibiotics. Bacteriol 1977; 130: 1357-63.